Rest of the question
actions you have taken and will continue to take to remediate the material weaknesses. Please revise to clarify 10. which of these efforts you have completed, if any, and which ones you are continuing to implement. Also, disclose how long you estimate it will take to complete your remediation plan and any associated expenses that you have incurred or expect to incur if material. Our substantial indebtedness could materially adversely affect our financial condition..., page 11. Please quantify your debt service requirements and disclose the percentage of your cash flow that must be dedicated to total debt service, including both principal and interest. The dual class structure of our common stock..., page 70 12. Please include a brief description of the Equity Exchange Rights held by your Co- Founders. Also, quantify the number of shares of Class A common stock subject to outstanding stock options to purchase shares of your Class A common stock held by your Co-Founders and the potential impact on their voting power. Use of Proceeds, page 80 13. Please disclose the interest rate and maturity of the Term Loan Facility. Refer to Instruction 4 to Item 504 of Regulation S-K. Management's Discussion and Analysis of Financial Condition and Results of Operations, 14. We note the growth of your business and revenues depends on retaining existing customers, expanding sales to those customers, and attracting new customers. Please tell us how you monitor customer retention, expansion and growth. If you consider these measures to be key performance measures that management utilizes to evaluate your business operations, revise to include relevant disclosure for all periods presented. Refer to SEC Release No. 33-10751. Attractive Unit Economics, page 92 15. We note your disclosure regarding average cash payback period. Please revise to include a definition of this term, and explain how it is calculated and what it is intended to convey. Non-GAAP Financial Measures, page 97 16. Please revise to move your non-GAAP information so that it follows the GAAP results of operations disclosure, to ensure the discussion and analysis of your GAAP measures are presented with equal or greater prominence. Similarly, revise the disclosures on page 22 to include GAAP net loss margin and GAAP operating income (loss) margin with equal or greater prominence to the related non-GAAP measures. Refer to Item 10(e)(1)(i)(A) of Regulation S-K and the guidance in Non- GAAP C&DI Question 102.10(a). Results of Operations, page 102 17. Please revise your revenue discussion to include quantified information regarding revenue growth due to new versus existing customers. Refer to Item 303(b) of Regulation S-K. 18. We note your discussion of several line items, such sales and marketing and general and administrative expense, attributes change as being “primarily” due to various factors and/or do not appear to describe all of the factors that impacted the fluctuation in such expenses. Where a material change is attributed to two or more factors, including any offsetting factors, revise to describe the contribution of each factor in quantified terms. Please also revise to use more definitive terminology rather than general or vague terms such as “primarily” to describe each contributing factor. Business Growth Strategies, page 129 19. Please disclose the basis for your statement that you pioneered the AI Hyperscaler. Our Customers, page 139 20. Please disclose the number of committed contract customers for all periods presented to provide context to your disclosure of the number of committed contract customers as of December 31, 2024. Intellectual Property, page 143 21. Please disclose the duration and effect of all patents and trademarks. Refer to Item 101(c)(1)(iii)(B) of Regulation S-K. Certain Relationships and Related Party Transactions Other Transactions, page 167 22. Please file the Master Services Agreement with NVIDIA and the MagAI Capacity Agreement with MagAI Ventures as exhibits to your registration statement. Refer to Item 601(b)(10)(ii)(A) of Regulation S-K. Underwriting (Conflicts of Interest), page 199 23. Please disclose the exceptions to the lock-up agreements with your officers, directors and principal stockholders. Notes to Consolidated Financial Statements Note 1. Overview and Summary of Significant Accounting Policies Concentration of Risk, page F-13 24. Please tell us whether the three customers who generated significant revenue for the year ended December 31, 2023, were the same or different than the two customers who generated significant revenue for the period ended September 30, 2024. Also, revise to distinguish the percentage of revenue attributed to each of your significant customers for each period presented by, for example, identifying each customer as customer A, customer B, customer C, etc. Property and Equipment, Net, page F-15 25. We note you depreciate equipment and software over a useful life ranging between 3years and 12-years. This category appears to include a variety of assets such as data centers and related capitalized interest costs, capitalized internal-use software, and networking and computer equipment. Please provide us with a breakdown of the various types of assets included here, and the related useful lives associated with each type of asset. Also, given the nature and function of these assets appear to vary, consider revising your disclosure to further disaggregate long-lived assets based on the similar nature or function of each type of asset, and include the related useful lives for each. Refer to ASC 360-10-50-1(b). Note 2. Revenue Disaggregation of Revenue, page F-24 26. Please revise to disclose the amount, or percentage, of total revenue generated in the United States, your country of domicile. Similarly, revise to disclose total long-lived assets held in the United States for each period. Refer to ASC 280-10-50-41. Remaining Performance Obligations, page F-25 27. We note from your disclosure on page F-20 that the remaining performance obligations (RPO) represent the aggregate amount of the transaction price, including estimated variable consideration. Please tell us what the variable consideration represents and how you determined the amount of variable consideration included in your RPO. In your response, provide us with the amount of variable consideration included in RPO for each period presented. 28. Please revise to clarify how long "thereafter" is with respect to your remaining performance obligations. In this regard, we note typical contract terms are two to five years. Revise to clarify the length of time over which the remaining performance obligation will be recognized after 24 months for each period presented. Refer to ASC 606-10-50-13. Note 11. Redeemable Convertible Preferred Stock and Stockholders' Deficit Stock Option Plan, page F-46 29. We note you include the fair value per share of your common stock, which is determined by your board of directors, as an assumption used in the valuation of equity awards granted. Please provide us a breakdown of all stock option and RSUs granted during fiscal 2024 and to date in 2025, as applicable, and include the fair value of the underlying common stock used to value such awards. To the extent the value of your common stock fluctuated significantly between measurement dates, describe for us the factors that contributed to these fluctuations, including any intervening events within the company or changes in your valuation assumptions or methodologies used to value such awards. Lastly, revise to include the fair values used to value such awards in your assumption disclosures on page F-47. General 30. Please supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications.